BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davoodi L, Abedi SM, Salehifar E, Alizadeh-Navaei R, Rouhanizadeh H, Khorasani G, Hosseinimehr SJ. Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial. Int J Clin Pract 2020;74:e13600. [PMID: 32603531 DOI: 10.1111/ijcp.13600] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Jacobson KB, Purington N, Parsonnet J, Andrews J, Balasubramanian V, Bonilla H, Edwards K, Desai M, Singh U, Hedlin H, Jagannathan P. Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19. Diagn Microbiol Infect Dis 2021;102:115612. [PMID: 34974350 DOI: 10.1016/j.diagmicrobio.2021.115612] [Reference Citation Analysis]
2 Chen Y, Li MX, Lu GD, Shen HM, Zhou J. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. Int J Biol Sci 2021;17:1538-46. [PMID: 33907517 DOI: 10.7150/ijbs.59547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Singh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database Syst Rev 2021;2:CD013587. [PMID: 33624299 DOI: 10.1002/14651858.CD013587.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
4 Davoodi L, Jafarpour H, Oladi Z, Zakariaei Z, Tabarestani M, Ahmadi BM, Razavi A, Hessami A. Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial. Int J Cardiol Heart Vasc 2021;36:100875. [PMID: 34541293 DOI: 10.1016/j.ijcha.2021.100875] [Reference Citation Analysis]
5 Cavanna L, Citterio C. Randomised clinical trials on outpatient treatment of SARS-COV-2 infection: Light and shadows. Int J Clin Pract 2021;75:e14896. [PMID: 34965649 DOI: 10.1111/ijcp.14896] [Reference Citation Analysis]
6 Juul S, Nielsen EE, Feinberg J, Siddiqui F, Jørgensen CK, Barot E, Holgersson J, Nielsen N, Bentzer P, Veroniki AA, Thabane L, Bu F, Klingenberg S, Gluud C, Jakobsen JC. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS One 2021;16:e0248132. [PMID: 33705495 DOI: 10.1371/journal.pone.0248132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
7 Stammes MA, Lee JH, Meijer L, Naninck T, Doyle-Meyers LA, White AG, Borish HJ, Hartman AL, Alvarez X, Ganatra S, Kaushal D, Bohm RP, le Grand R, Scanga CA, Langermans JAM, Bontrop RE, Finch CL, Flynn JL, Calcagno C, Crozier I, Kuhn JH. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates. Trends Mol Med 2021:S1471-4914(21)00316-6. [PMID: 34955425 DOI: 10.1016/j.molmed.2021.12.001] [Reference Citation Analysis]
8 Kashour Z, Kashour T, Gerberi D, Tleyjeh IM. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials. Clin Transl Sci 2021;14:1101-12. [PMID: 33606894 DOI: 10.1111/cts.13001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, Pardo-Hernandez H, Qasim A, Martinez JPD, Rochwerg B, Lamontagne F, Han MA, Liu Q, Agarwal A, Agoritsas T, Chu DK, Couban R, Cusano E, Darzi A, Devji T, Fang B, Fang C, Flottorp SA, Foroutan F, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Hou X, Ibrahim Q, Khamis A, Lam B, Loeb M, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Neary JD, Rada G, Riaz IB, Sadeghirad B, Sekercioglu N, Sheng L, Sreekanta A, Switzer C, Tendal B, Thabane L, Tomlinson G, Turner T, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Ye Z, Guyatt GH, Brignardello-Petersen R. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ 2020;370:m2980. [PMID: 32732190 DOI: 10.1136/bmj.m2980] [Cited by in Crossref: 196] [Cited by in F6Publishing: 181] [Article Influence: 98.0] [Reference Citation Analysis]
10 Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, Condo J, Decloedt EH, Nachega JB, Reis G, Mills EJ. How COVID-19 has fundamentally changed clinical research in global health. Lancet Glob Health 2021;9:e711-20. [PMID: 33865476 DOI: 10.1016/S2214-109X(20)30542-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
11 Juul S, Nielsen EE, Feinberg J, Siddiqui F, Jørgensen CK, Barot E, Nielsen N, Bentzer P, Veroniki AA, Thabane L, Bu F, Klingenberg S, Gluud C, Jakobsen JC. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS Med 2020;17:e1003293. [PMID: 32941437 DOI: 10.1371/journal.pmed.1003293] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
12 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bayraktar Y, Özyılmaz A, Toprak M, Işık E, Büyükakın F, Olgun MF. Role of the Health System in Combating Covid-19: Cross-Section Analysis and Artificial Neural Network Simulation for 124 Country Cases. Social Work in Public Health 2021;36:178-93. [DOI: 10.1080/19371918.2020.1856750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Nugrahani I, Parwati RD. Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development. Molecules 2021;26:4185. [PMID: 34299458 DOI: 10.3390/molecules26144185] [Reference Citation Analysis]
15 Honarmand K, Penn J, Agarwal A, Siemieniuk R, Brignardello-Petersen R, Bartoszko JJ, Zeraatkar D, Agoritsas T, Burns K, Fernando SM, Foroutan F, Ge L, Lamontagne F, Jimenez-Mora MA, Murthy S, Yepes-Nuñez JJ, Vandvik PO, Ye Z, Rochwerg B. Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality. J Clin Epidemiol 2021;139:68-79. [PMID: 34274489 DOI: 10.1016/j.jclinepi.2021.07.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Bokharee N, Khan YH, Khokhar A, Mallhi TH, Alotaibi NH, Rasheed M. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. Expert Rev Anti Infect Ther 2021;:1-26. [PMID: 33719819 DOI: 10.1080/14787210.2021.1902805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, Rezaie E, Ghaleh HEG, Aghamollaei H, Fasihi-Ramandi M, Hassanpour K, Alishiri G. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial. Arch Med Res 2021:S0188-4409(21)00141-7. [PMID: 34229896 DOI: 10.1016/j.arcmed.2021.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rai SN, Qian C, Pan J, Seth A, Srivastava DK, Bhatnagar A. Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients. BMC Med Res Methodol 2020;20:220. [PMID: 32867708 DOI: 10.1186/s12874-020-01101-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Welte T, Ambrose LJ, Sibbring GC, Sheikh S, Müllerová H, Sabir I. Current evidence for COVID-19 therapies: a systematic literature review. Eur Respir Rev 2021;30:200384. [PMID: 33731328 DOI: 10.1183/16000617.0384-2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]